Dynavox Group (DYVOX) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Dynavox Group stock SEK 32.16, price SEK 70.80, that is 54.6% below the price, quality 51 out of 100. Rating: strongly overvalued. Calculated from audited financials with 12 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Dynavox Group
DYVOX · STOur calculation puts a fair price 55% below what the stock costs today.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
59‑month range kr 17.61 – kr 130.52 · fair‑value band kr 21.97 – kr 42.34 · the kr 70.80 price screens above the kr 32.16 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Every Wednesday you see whether Dynavox is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities.
Show moreShow less
The company offers custom designed augmentative and alternative communication (AAC) solutions that enable people with disabilities, such as cerebral palsy, ALS, autism, and spinal cord injury, to communicate on their own.
Its communication solutions include language, software, hardware, funding, support, and training. The company operates in Sweden, Norway, Denmark, Belgium, the United States, Germany, France, China, the United Kingdom, Ireland, Australia, and New Zealand.
The company was formerly known as Tobii Dynavox AB (publ) and changed its name to Dynavox Group AB (publ) in July 2024. Dynavox Group AB (publ) was incorporated in 2012 and is headquartered in Stockholm, Sweden.
Stock analysis
Dynavox Group (DYVOX) currently trades at kr 70.80, while our model-based Fair Value estimate is kr 32.16, 55% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of kr 49.83 per share, and 1 of the 12 models we run sit above the kr 70.80 price.
Bear case: the Economic Profit group reads lowest at kr 18.08, and 11 of the 12 models stay below the price. Data coverage for this calculation is medium.
Scenario range: kr 21.97 (bear) to kr 42.34 (bull), the price of kr 70.80 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 51/100 (solid quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Dynavox Group reported revenue of 2.5B SEK in FY2025 versus 871M SEK in FY2021, a compound +29.7%/yr. Reported net income was 166M SEK in FY2025, compounding +53.6%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.
Key figures
Market cap 7.5B SEK (≈ $764M) Small · P/E ratio 27.4 · P/S ratio 2.88 · EPS (TTM) kr 2.58 · Dividend yield 0.7% · Net margin 10.5% · Return on equity 40.4% · Return on assets (EBIT) 8.4% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 65 out of 100 (low confidence).
What moves the price
The share trades about 32% below its 52-week high and 22% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at −55%, DYVOX screens richer than that median.
Fair Value models
All 12 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
DYVOX screens overvalued: fair value 55% below the price. Compare with Intuitive Surgical, Inc →
Compare Dynavox Group with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 181 stocks
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Net margin by industry
- P/B ratio by industry
- Piotroski F-Score screener with fair value
- Valuation of the Sweden market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Solventum Corporation SOLV | $90.38 | $131.27 | +45% | vs DYVOX |
| EssilorLuxottica Société anonyme EL | €193.80 | €196.22 | +1% | vs DYVOX |
| Intuitive Surgical, Inc ISRG | $452.80 | $353.90 | −22% | vs DYVOX |
| Medline Inc MDLN | $39.64 | $28.59 | −28% | vs DYVOX |
| Alcon Inc ALC | CHF 61.30 | CHF 34.06 | −44% | vs DYVOX |
| Becton, Dickinson and Company BDX | $211.88 | $97.80 | −54% | vs DYVOX |
| Straumann Holding STMN | CHF 104.50 | CHF 45.50 | −56% | vs DYVOX |
| West Pharmaceutical Services, Inc WST | $399.81 | $139.22 | −65% | vs DYVOX |
| Sartorius Stedim Biotech S.A DIM | €225.80 | €54.82 | −76% | vs DYVOX |
| Sartorius Aktiengesellschaft SRT | €227.00 | €42.50 | −81% | vs DYVOX |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Dynavox Group (DYVOX) overvalued or undervalued?
What is the fair value of DYVOX?
What is the quality score of DYVOX?
What is the price target for Dynavox Group (DYVOX)?
What is the Dynavox Group stock forecast for 2026?
What is the revenue of Dynavox Group (DYVOX)?
Does Dynavox Group pay a dividend?
How much is the dividend of Dynavox Group (DYVOX) and when is the ex-dividend date?
What is the intrinsic value of Dynavox Group (DYVOX)?
Is Dynavox Group stock overvalued or undervalued in 2026?
Is fair value the same as the market price of DYVOX?
How much is Dynavox Group worth?
What do the bullish and bearish scenarios say about DYVOX?
What is the P/E ratio of DYVOX?
How solid is the balance sheet of Dynavox Group (DYVOX)?
How far is DYVOX from its 52-week high?
Which stocks are comparable to Dynavox Group?
Is Dynavox Group stock attractive at the current price?
How is the fair value of DYVOX calculated?
Is it still worth investing in stocks now?
What is the share price of Dynavox Group (DYVOX)?
What should I pay attention to with Dynavox Group right now?
Key figures of Dynavox Group
How large is the market capitalisation of Dynavox Group (DYVOX)?
What is the P/S ratio of Dynavox Group (DYVOX)?
What are the earnings per share of Dynavox Group (DYVOX)?
What is the dividend yield of Dynavox Group (DYVOX)?
What is the net margin of Dynavox Group (DYVOX)?
What is the return on equity of Dynavox Group (DYVOX)?
What is the EBIT return on assets of Dynavox Group (DYVOX)?
What is the operating margin of Dynavox Group (DYVOX)?
How fast is revenue growing at Dynavox Group (DYVOX)?
How fast are earnings growing at Dynavox Group (DYVOX)?
How much free cash flow does Dynavox Group (DYVOX) generate?
How much net debt does Dynavox Group (DYVOX) carry?
Watch Dynavox Group in the live analysis
One click puts Dynavox Group on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.